Promoting Health, Safety and Equity

Harm Reduction Innovation Lab

401-212-4730

  • Home
  • About Us
    • What is Harm Reduction?
    • Meet the Team
    • Mission, Vision, & Values
    • Contact Us
  • Research Projects
    • Drug Checking
    • OD Detection Technologies
    • Sleep and MOUD
    • Completed Projects
  • Publications and Posters
    • Publications
    • Research Posters
    • Select Presentations
  • Resources
    • Infographics
    • Additional Websites
  • Español
    • Inicio
    • Reducción de Danos
    • Conoce al Equipo
    • Misión, Visión & Valores
    • Trabajos de Investigación
    • Publicaciones y Posteres
    • Recursos
  • More
    • Home
    • About Us
      • What is Harm Reduction?
      • Meet the Team
      • Mission, Vision, & Values
      • Contact Us
    • Research Projects
      • Drug Checking
      • OD Detection Technologies
      • Sleep and MOUD
      • Completed Projects
    • Publications and Posters
      • Publications
      • Research Posters
      • Select Presentations
    • Resources
      • Infographics
      • Additional Websites
    • Español
      • Inicio
      • Reducción de Danos
      • Conoce al Equipo
      • Misión, Visión & Valores
      • Trabajos de Investigación
      • Publicaciones y Posteres
      • Recursos
Harm Reduction Innovation Lab

401-212-4730

  • Home
  • About Us
    • What is Harm Reduction?
    • Meet the Team
    • Mission, Vision, & Values
    • Contact Us
  • Research Projects
    • Drug Checking
    • OD Detection Technologies
    • Sleep and MOUD
    • Completed Projects
  • Publications and Posters
    • Publications
    • Research Posters
    • Select Presentations
  • Resources
    • Infographics
    • Additional Websites
  • Español
    • Inicio
    • Reducción de Danos
    • Conoce al Equipo
    • Misión, Visión & Valores
    • Trabajos de Investigación
    • Publicaciones y Posteres
    • Recursos

Publications

harm reduction

Situating the Continuum of Overdose Risk in the Social Determinants of Health

Situating the Continuum of Overdose Risk in the Social Determinants of Health

Situating the Continuum of Overdose Risk in the Social Determinants of Health

This article reconceptualizes our understanding of the opioid epidemic and proposes six strategies that address the epidemic’s social roots.

Read More

NASEM Workshop

Situating the Continuum of Overdose Risk in the Social Determinants of Health

Situating the Continuum of Overdose Risk in the Social Determinants of Health

Dr. Park presented at the National Academies of Sciences workshop.  This Proceedings of a Workshop—in Brief highlights the presentations and discussions that occurred at the workshop. 

Read More

Overdose Epidemiology

Time-Space Characteristics of EMS Attendance & Layperson Naloxone Use During Non-Fatal Overdoses...

Time-Space Characteristics of EMS Attendance & Layperson Naloxone Use During Non-Fatal Overdoses...

Time-Space Characteristics of EMS Attendance & Layperson Naloxone Use During Non-Fatal Overdoses...

Led by Dr. Rosen, EMS response to non-fatal overdoses were characterized by the time they were treated and where they were located (e.g., residential housing, outdoor spaces).

Read more

Bystander Presence & Naloxone Admin. During Fatal Overdoses in RI: Naloxone Coverage Implications

Time-Space Characteristics of EMS Attendance & Layperson Naloxone Use During Non-Fatal Overdoses...

Time-Space Characteristics of EMS Attendance & Layperson Naloxone Use During Non-Fatal Overdoses...

Thie study investigates trends in fetal opioid-involved overdose deaths, especially in regards to the environment and whether bystanders were present, with naloxone. Equipping responders with timely naloxone intervention may address overdose fatalities.

Read more

OD Detection Technologies

Overdose Detection Technologies to Reduce Solitary Overdose Deaths: A Literature Review

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices

Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths

Led by undergraduate student Alexa Lombardi, this paper is a review of the various different types of overdose prevention tech that exist today. 

read more

Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices

Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths

A JAMA Psychiatry commentary led by Dr. Park on the importance of  understanding the impact, scalability, and cost-effectiveness of overdose detection technology for overdose prevention

Read more

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices

Evaluating the Impact of Brave Technology Co-op’s Novel Drug Overdose Detection and Response Devices

This study assesses the preliminary impact of Brave Technology Co-op’s overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North America.

Read more

Drug Checking

North American Drug Checking Survey

North American Drug Checking Survey

North American Drug Checking Survey

Led by Dr. Park, drug checking programs operating in the US, Canada and Mexico were surveyed to understand their establishment and operations.

Read more

Validation of Fentanyl Test Strips

North American Drug Checking Survey

North American Drug Checking Survey

Latest study from Johns Hopkins University on fentanyl test strips used for detecting fentanyl in drugs.

Read more

Costing analysis of a point-of-care drug checking program in Rhode Island

A need for community lot testing of Fentanyl Test Strips marketed for harm reduction

A need for community lot testing of Fentanyl Test Strips marketed for harm reduction

This was a costing analysis of a new pilot drug checking service that employed an FTIR spectrometer, fentanyl test strips and confirmatory testing in Rhode Island from January 2023-May 2023. 

Read more

A need for community lot testing of Fentanyl Test Strips marketed for harm reduction

A need for community lot testing of Fentanyl Test Strips marketed for harm reduction

A need for community lot testing of Fentanyl Test Strips marketed for harm reduction

The authors argue the high demand of FTS with poor regulations lead some manufacturers to not field test their test strips, causing the authors to urge communities to set a lot checking program in place.

Read more

Drug Policy

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

Following changes to drug criminalization policies, this article re-examines the epidemiology of drug arrests among people who use drugs (PWUD) in the U.S.

Read more

Drug decriminalization, fentanyl, and fatal overdoses in Oregon

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

This was an analysis that evaluated whether the decriminalization of drug possession in Oregon was associated with changes in fatal overdose rates, after accounting for fentanyl contaminating the unregulated drug market.

Read more

A comprehensive response to the fentanyl crisis: Strengthening response to fentanyl...

Epidemiology of drug arrests in the US: Evidence from the national survey on drug use and health

A comprehensive response to the fentanyl crisis: Strengthening response to fentanyl...

Dr. Park testified to the Senate Judiciary Committee in February 2025 on a comprehensive response to the fentanyl crisis.


Read more

SOLITARY drug USE & Supervised Consumption

Safety in Solitude? Competing Risks and Drivers of Solitary Drug Use

Supervised Inhalation Sites: Preventing Overdose & Reducing Health Inequities among People Who Use

Willingness to use supervised consumption spaces in Providence, Boston, Baltimore

Led by doctoral student Greg Rosen, this paper explores the understudied phenomenon of solitary drug use.

READ MORE

Willingness to use supervised consumption spaces in Providence, Boston, Baltimore

Supervised Inhalation Sites: Preventing Overdose & Reducing Health Inequities among People Who Use

Willingness to use supervised consumption spaces in Providence, Boston, Baltimore

Most people who use opioids would use these services if they were available.

Read more

Supervised Inhalation Sites: Preventing Overdose & Reducing Health Inequities among People Who Use

Supervised Inhalation Sites: Preventing Overdose & Reducing Health Inequities among People Who Use

Supervised Inhalation Sites: Preventing Overdose & Reducing Health Inequities among People Who Use

This commentary led by Alison Lu and Claire Kim considers why supervised inhalation sites (SIS) are needed, highlights operational characteristics of four existing services, and advocates for future SIS research.

Read more

Stigma & disparities

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the US

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the US

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the US

This article characterizes longitudinal patterns and demographic disparities in new HIV diagnoses attributed to injection drug use (IDU) in 2008–2020. 

Read more

“Make yourself un-NIMBY-able”: stakeholder perspectives on OPC authorization strategies

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the US

Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the US

This article examines interview transcript with shareholders of OPC's and breaks down the multiple social, political, and legal obstacles 

Read more

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking

This article found that stigma is throughout the OPC authorization process, from planning to authorization, and elaborates on the thoughts of advocates, legislators, service providers, and researchers.

Read more

Knowledge, Attitudes, and Beliefs About Opioid Use Disorder Treatment in Primary Care

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking

"Politics Versus Policy": Qualitative Insights on Stigma and Overdose Prevention Center Policymaking

The article examines the public's perceptions of primary care providers (PCPs) and their ability to prescribe medication to treat OUD. It finds most people are open to receiving this treatment from their PCP, which suggests screening to improve MOUD access is needed.

Read more

Naloxone

High-Dose Naloxone Formulations Are Not as Essential as We Thought

Disruptions to naloxone training among lay and occupational responders in Maryland during COVID

Disruptions to naloxone training among lay and occupational responders in Maryland during COVID

This literature review, led by Tennessee Harm Reduction, investigated the adequacy of the regularly distributed two doses of standard low-dose naloxone in reversing fentanyl overdoses and whether high-dose naloxone formulations (HDNF) are an optimal solution to this problem. 

Read more

Disruptions to naloxone training among lay and occupational responders in Maryland during COVID

Disruptions to naloxone training among lay and occupational responders in Maryland during COVID

Disruptions to naloxone training among lay and occupational responders in Maryland during COVID

This article investigated changes in the number of people trained in naloxone administration and distribution in Maryland before, during, and after COVID-related stay-at-home orders. 

Read more

Dr. Park's Bibliography

Get to know more about harm reduction, overdose prevention, and more that have been published by our lab's PI.

Read more
  • Contact Us

Harm Reduction Innovation Lab

1125 North Main Street, Providence, Rhode Island 02904, United States

401-212-4730

Copyright © 2024 Harm Reduction Innovation Lab - All Rights Reserved.

Powered by